Does MEPOLIZUMAB Cause Peripheral swelling? 968 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 968 reports of Peripheral swelling have been filed in association with MEPOLIZUMAB (Nucala). This represents 2.3% of all adverse event reports for MEPOLIZUMAB.
968
Reports of Peripheral swelling with MEPOLIZUMAB
2.3%
of all MEPOLIZUMAB reports
529
Deaths
614
Hospitalizations
How Dangerous Is Peripheral swelling From MEPOLIZUMAB?
Of the 968 reports, 529 (54.6%) resulted in death, 614 (63.4%) required hospitalization, and 445 (46.0%) were considered life-threatening.
Is Peripheral swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 968 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Peripheral swelling?
ADALIMUMAB (13,837)
ETANERCEPT (12,654)
METHOTREXATE (10,632)
TOCILIZUMAB (8,030)
TOFACITINIB (7,830)
ABATACEPT (7,561)
LEFLUNOMIDE (7,254)
LENALIDOMIDE (6,364)
HYDROXYCHLOROQUINE (6,128)
RITUXIMAB (5,977)
Which MEPOLIZUMAB Alternatives Have Lower Peripheral swelling Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE